CDKN1A (p21), a cell cycle-dependent kinase inhibitor, has been identified as a target gene downstream of p53 and can promote apoptosis in many tumor types by activating the TNF receptor or inducing the proapoptotic protein BAX [21, 22]. This evidence concerns the gene TP53 and neoplasm.